Long-Term Liabilities: The sum of all non-current liabilities.
Cognition Therapeutics, Inc. (CGTX) had Long-Term Liabilities of $0.42M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.93M |
|
-- |
|
-- |
|
$7.74M |
|
$-7.74M |
|
$3.81M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-7.74M |
|
$-7.68M |
|
90.62M |
|
90.62M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$38.30M |
|
$0.09M |
|
$0.60M |
|
$38.90M |
|
$5.45M |
|
-- |
|
|
Long-Term Liabilities |
$0.42M |
$5.87M |
|
$33.02M |
|
$33.02M |
|
$33.02M |
|
95.06M |
|
| Cash Flow Statement Financials | |
$-8.60M |
|
$-0.02M |
|
$6.38M |
|
$37.00M |
|
$34.76M |
|
$-2.24M |
|
$0.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.91% |
|
-11.91% |
|
-10.11% |
|
-11.91% |
|
$0.35 |
|
$-0.10 |
|
$-0.09 |
|